Revelation Biosciences REVB Cash Flow Statement (2020-2026)

NASDAQ REVB
$1.07 -0.02 (-2.30%)
As of: Aug 21, 2026 · 11:18 AM EDT
Cash Flow Statement Mar2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income (Quarter)
-2.44M-3.04M-4.21M-6.64M-1.89M-1.22M-1.59M-1.71M-1.99M-2.81M-12.83M-1.94M-2.55M-1.81M-2.23M-2.09M-2.46M-1.94M-2.71M-3.66M
Depreciation and Depletion (Quarter)
642.000.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Share-based Compensation (Quarter)
0.13M0.13M0.11M0.14M0.09M0.04M0.03M0.03M0.06M0.03M0.16M0.03M0.03M0.03M0.07M873.000.37M0.40M
Gains from Investment Securities (Quarter)
0.49M-0.09M0.25M8.20M-7.74M-0.42M-0.09M-0.07M-0.07M-0.00M-0.01M-0.00M-0.00M-44.00-611.00-87.00
Cash from Operations (Quarter)
-3.59M-2.23M-2.88M-4.83M-3.71M-1.73M-0.95M-1.58M-1.99M-1.72M-2.00M-2.84M-2.48M-9.26M-3.75M-2.79M-1.92M-1.59M-1.97M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
642.000.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Change in Working Capital
Change in Account Payables (Quarter)
-0.18M0.12M-0.43M0.26M-0.54M-0.45M0.07M0.17M0.21M0.34M0.03M0.32M-0.40M1.85M-2.34M-0.16M0.20M0.19M-0.44M
Change in Accured Expenses (Quarter)
0.47M0.43M0.38M1.39M-1.54M-0.42M-0.02M0.00M-0.48M0.53M0.11M-0.53M6.31M-8.90M0.19M-0.66M0.28M0.05M0.60M
Other Working Capital Changes (Quarter)
1.56M-0.12M-0.93M0.04M-0.11M-0.27M-0.24M0.26M-0.08M-0.10M-0.07M-0.01M0.05M-0.01M-0.05M0.16M-0.04M-0.06M-0.03M
Investing Activities
Capital Expenditures (Quarter)
0.05M-0.02M0.02M0.02M-0.02M
Change in Acquisitions & Divestments (Quarter)
0.07M0.28M0.04M
Cash from Investing Activities (Quarter)
-0.05M0.02M-0.02M-0.02M0.02M
Financing Activities
Other financing activities (Quarter)
0.01M-0.01M0.01M14.03M5.42M-5.42M5.42M3.39M-3.03M
Cash from Financing Activities (Quarter)
10.74M4.45M0.01M14.02M15.005.42M3.74M3.69M9.12M-0.04M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Change in Cash (Quarter)
-3.64M-2.23M-2.86M5.91M-3.71M2.72M-0.94M12.45M-1.99M-1.72M-2.00M2.56M-2.48M-5.53M-0.04M-2.79M1.47M7.53M-2.01M
Free Cash Flow (Quarter)
-3.64M-2.23M-2.86M-4.83M-3.71M-1.73M-0.95M-1.58M-1.99M-1.72M-2.00M-2.86M-2.48M-9.27M-3.73M-2.79M-1.92M-1.59M-1.97M
Net Cash Flow (Quarter)
-3.64M-2.23M-2.86M5.91M-3.71M2.72M-0.94M12.45M-1.99M-1.72M-2.00M2.56M-2.48M-5.53M-0.04M-2.79M-1.92M7.53M-2.01M